I walked through the supplement isle in Costco yesterday, and it just bugs me that Nutrex wants to market their products right next to the Nature's Made #$%$. But I guess that's all we're ever going to get with Bailey. He'll never be a Jacobson, and I don't think he'll ever do anything but continue to cheapen the Nutrex brand. I hope I'm wrong, but this guy just doesn't strike me as someone who can successfully market this product.
I don't quite understand why the company needs to sell astaxanthin through Costco. I purchase my supplements from either a health food store or on-line. I'm a Costco member, but I don't purchase supplements from them (or at Walmart either). Are sales to Costco going to be at a higher margin than what they are to Whole Foods?
I just started looking at this company, and I'm concerned about the composition of the Board of Directors and the lack of information regarding the qualifications of senior management. Two of the directors, Ms. Beard & Ms. Conard own no stock in the company. Ms. Beard, a CPA, has been on the board since 2003, and Ms. Conard, a high level manager at Franklin Templeton, since 2011. It's a sad statement that these two members, who represent the financial experience of this board, do not find that this company is a good investment. It's also sad that they don't have the confidence in their abilities as board members to lead a company that is worthy of their own investment. Furthermore, why is there a need to have two members with insurance backgrounds? In regard to management, the latest proxy statement is very weak (meaning nothing at all) in its profile of the company's senior management. I wonder if this management team has any educational background. Did daddy not send his boy to college? What did the VP of operations do besides work a few years in retail? I don't get this. Maybe somebody can help me out.
My heavens! They're paying over 15% for the line of credit they just received from this Summit outfit. Are they in this much trouble, or is there some kind of insestial relationship between Swenson & the lender?
I was just looking over the proxy statement. I was not aware that Mike Davis did not have a college degree. His profile indicates that he "attended Harvard University." I wonder in what capacity he attended Harvard, if he was actually enrolled, and if so, when he dropped out. I think it's appalling that this company's board is being led by at best a college drop-out. No wonder this company is in such a mess. An unqualified board and suspect management. It's beginning to look like a proxy contest is going to be needed to right this ship.
Just my humble opinion, but Michael Davis needs to get his head out of his a??, act like a Chairman of the Board, and do something about the company's incompetent management. It's way past time. This management team was brought in by the equally incompetent Robertson and Rosenthal (check out Gregg Robertson's linked-in page and see his glowing letter of recommendation of Rosenthal - who else would recommend him). What a joke these people are. Given any additional time and Bailey will destroy the entire astaxanthin supplement category (if he hasn't already done so). The quality of Bioastin went to crud under his leadership, he #$%$ away tons of cash by miring the company in senseless litigation, he's lost all momentum in sales, and now he's borrowing money at extremely high interest rates (in excess of 6%). I expect that the reason that he won't communicate with shareholders is that he fears it would expose his incompetence.
The only thing I can figure regarding today's price action is concern that NGVC will post results that may mirror those of Whole Foods' results announced yesterday. Either that or there was a leak of the quarterly results.
It's good to see some recent insider buying by new CEO Van Kirk as well as Swenson and Cabillot. Hopefully, this is an indication that PDEX will be back in the black in the June 4th quarter.
Maybe Mike Davis can apologize to Andy Jacobson and get him to come back. He dug the company out the pits in a short period his last time around but was shoved out for no apparent reason by Gregg Robertson and David Rosenthal.
Why doesn't Mr. Saraf explain in his proxy letter how he manipulated the stock just before he exercised his options a few weeks ago. He announced a large dividend which gave a quick boost to the stock, then exercised his options, sold a portion of the stock to pay for the stock he purchased at the inflated price PLUS collected the dividend that he initiated. This guy needs to be reigned in. Voting for the Erikson proposal is a good start.
I'm trying to figure out why when the company earned $0.24 per share last quarter that the earnings estimate for this quarter is only $0.15. Can anyone (with any analytical skills) help me with this?
I agree with southwalled regarding the BOD. This company has never had any decent board direction or oversite, but have (until just recently with their astaxanthin) produced very good products, and their spirulina is by far the best in the industry. The sales growth for spirulina looks outstanding in both bulk and branded, and I hope they don't neglect this product at the expense of astaxanthin. But I do hope they've finally got it right and can start firing on all cylinders, because they've rocketed up their overhead to the point where they'll have difficulty surviving another major screw up.
ohcguy, do you actually use astaxanthin?
I can't teach you how to read, but today's press release has three mentions of how the company is attempting to improve the quality of the product. If there's not a quality issue, then why try to improve it? Why hire two high level employees if there's no need?
As far as your assumptions, I have substantial stock holdings in the company and have been a stockholder since the early 90's. I have no affiliation with Valensa.
Had they not started the fight with Valensa and continued to work with them they would never had an issue with the extraction (Valensa did a good job) nor would they have had to fight a lawsuit, and how different things would look now! Arrogance gets you nowhere, Mr. Bailey.
Unfortunately, I don't think the first quarter will be any better than the fourth. I would opine that the New Zealand extraction set-up has been a fiasco that they (management) have played down. They repeatedly mentioned quality issues and this has obviously been going on for quite a while, and in my experience has negatively affected the quality of the end product. This is extremely unfortunate, because users are not experiencing the positive effects of the astaxanthin that they would otherwise be experiencing. Fortunately, with the new equipment this issue should be behind them and product quality should improve immensely, however, all the marketing efforts over the past few years have been wasted on a less than quality product that I would guess is still on the shelves at this point, and I don't think that consumers are going to want to repurchase a product that doesn't provide the intended benefits.